In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

  • Dr. Ian E. Krop led a study showing that the anti-body drug ado-trastuzumab emtansine significantly prolonged progression-free survival in patients with progressive HER2-positive advanced breast cancer.

Tags: BreastCancer

  • Dr. Eric P. Winer co-chaired an expert panel that developed a clinical practice guideline on disease management for patients with advanced HER2-positive breast cancer and brain metastases.

Tags: BreastCancer

  • Dr. Matthew Meyerson led a genomic study of lung cancer which has provided information that could help scientists devise new treatments.

Tags: Genomics

  • Dr. Paul L. Nguyen led a study showing prostate cancer patients with health insurance are less likely to have metastatic disease or die from the cancer than those without health insurance.

Tags: ProstateCancer

  • Dr. Robert Haddad commented on JPMorgan Chase CEO Jamie Dimon being diagnosed with throat cancer.

Tags: HeadNeckCancers

  • Dr. Joyce Liu commented on the Oncologic Drugs Advisory Committee vote to delay approval of the PARP inhibitor olaparib.

Tags: OvarianCancer

  • Johnson & Johnson Innovation Center will fund a $10 million partnership with Dana-Farber and Janssen Biotech to work on lung cancer immunotherapy drugs.

Tags: Immunotherapy

  • Dr. Erica Mayer, a medical oncologist at the Susan F. Smith Center for Women's Cancers at Dana-Farber, explained the concerns over soy consumption and its relationship to breast cancer.

Tags: BreastCancer

  • Dana-Farber is seeking alternative sources for research funding amid a downward trend in the money received from the federal government.

Tags: BasicResearch

  • Dr. Patrick Ott commented on the increased rates of melanoma in older adults.

Tags: Melanoma

Showing 31-40 of 438 items